Cure My Disease

Don't miss your cure!

 Log in / Sign up

New probe aims to zap lung tumors through a scope

NCT ID NCT05281237

Recruiting now Disease control Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a flexible microwave ablation probe that can be guided through a bronchoscope to destroy small lung cancer nodules (up to 3 cm) before surgical removal. Ten people with stage I-II lung cancer will receive the ablation during a bronchoscopy, and the treated tissue will be examined after surgery to see how much of the tumor was killed. The goal is to see if this less invasive approach is feasible and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AveCure flexible microwave ablation probe (device)
What this could lead to
If successful, this could offer a less invasive way to treat early-stage lung cancer by destroying tumors through a bronchoscope before surgery.
What could go wrong
This is a very small early feasibility study with only 10 participants, so results may not apply broadly. The procedure may not fully destroy the tumor or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER LUNG CANCER STAGE I LUNG CANCER STAGE II STAGE I - II PRIMARY LUNG CANCER STAGE I LUNG CANCER STAGE II LUNG CANCER

Contacts and locations

Locations

  • Beth Israel Deaconess Medical Center

    RECRUITING

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.